Pàgina inicial > Resultats de la cerca: Portal hypertension
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 6 registres trobats en 0.03 segons.
Articles, 5 registres trobats
Documents de recerca, 1 registres trobats
Articles 5 registres trobats  
1.
20 p, 2.0 MB A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo / Pinheiro, Iris (MRM Health NV) ; Barberá Bellés, Aurora (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Raurell, Imma (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Estrella, Federico (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Leeuw, Marcel (MRM Health NV) ; Bolca, Selin (MRM Health NV) ; Gottardi, Davide (MRM Health NV) ; Horscroft, Nigel (MRM Health NV) ; Possemiers, Sam (MRM Health NV) ; Salcedo, Maria-Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Genescà Ferrer, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martell, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Augustin Recio, Salvador (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
The gut microbiome has a recognized role in Non-alcoholic fatty liver disease (NAFLD) and associated comorbidities such as Type-2 diabetes and obesity. Stool transplantation has been shown to improve disease by restoring endothelial function and insulin signaling. [...]
2022 - 10.3390/biomedicines10051191
Biomedicines, Vol. 10 (may 2022)  
Registre complet - Creative Commons
2.
3 p, 772.9 KB Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD : A proof of concept case report / Rivera-Esteban, Jesús (Hospital Universitari Vall d'Hebron) ; Barberá Bellés, Aurora (Hospital Universitari Vall d'Hebron) ; Salcedo, Maria-Teresa (Hospital Universitari Vall d'Hebron) ; Martell, Maria (Hospital Universitari Vall d'Hebron) ; Genescà Ferrer, Joan (Hospital Universitari Vall d'Hebron) ; Pericàs, Juan M. (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
2022 - 10.1016/j.jhepr.2022.100618
JHEP Reports, Vol. 5 (october 2022)  
Registre complet - Creative Commons
3.
6 p, 292.0 KB Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis / Garcia Garcia de Paredes, Ana (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Villanueva, Càndid (Institut d'Investigació Biomèdica Sant Pau) ; Blanco, Carolina (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Genescà Ferrer, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Manicardi, Nicolo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Garcia-Pagan, Juan Carlos (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Calleja, Jose Luis (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Aracil, Carlos (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Morillas Cunill, Rosa Ma (Universitat Autònoma de Barcelona) ; Poca Sans, Maria (Institut d'Investigació Biomèdica Sant Pau) ; Peñas, Beatriz (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Augustin Recio, Salvador (Hospital Universitari Vall d'Hebron) ; Abraldes, Juan G. (University of Alberta) ; Alvarado-Tapias, Edilmar (Institut d'Investigació Biomèdica Sant Pau) ; Royo, Félix (Exosomes Laboratory. Center for Cooperative Research in Biosciencies (CIC bioGUNE). Basque Research and Technology Alliance (BRTA)) ; García-Bermejo, Mª Laura (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Falcon-Perez, Juan Manuel (Exosomes Laboratory. Center for Cooperative Research in Biosciencies (CIC bioGUNE). Basque Research and Technology Alliance (BRTA)) ; Bañares, Rafael (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; Bosch, Jaime (Department of Biomedical Research and University Clinic for Visceral Medicine and Surgery. Inselspital) ; Gracia-Sancho, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Albillos, Agustín (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Universitat Autònoma de Barcelona
Background & Aims: Treatment with non-selective beta-blockers (NSBBs) reduces the risk of ascites, which is the most common decompensating event in cirrhosis. This study aimed to assess the ability of a serum microRNA (miRNA) signature to predict ascites formation and the hemodynamic response to NSBBs in compensated cirrhosis. [...]
2021 - 10.1016/j.jhepr.2021.100368
JHEP Reports, Vol. 3 Núm. 6 (december 2021) , p. 100368  
Registre complet - Creative Commons
4.
10 p, 402.5 KB Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis / Rivera-Esteban, Jesús (Universitat Autònoma de Barcelona) ; Armandi, Angelo (University of Turin) ; Augustin Recio, Salvador (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bugianesi, Elisabetta (University of Turin)
Non-alcoholic steatohepatitis has emerged as a major public health problem, and the burden of non-alcoholic steatohepatitis cirrhosis is projected to increase by 64%-156% by 2030. The threat is aggravated by the fact that are currently no approved drugs for the treatment of non-alcoholic steatohepatitis. [...]
2021 - 10.1111/liv.15013
Liver International, Vol. 41 (july 2021) , p. 1999-2008  
Registre complet - Creative Commons
5.
19 p, 1.2 MB Spontaneous portosystemic shunts in liver cirrhosis : new approaches to an old problem / Vidal-González, Judit (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Quiroga, Sergi (Hospital Universitari Vall d'Hebron) ; Simon-Talero, Macarena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Genescà Ferrer, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Portal hypertension is the main consequence of liver cirrhosis, leading to severe complications such as variceal hemorrhage, ascites or hepatic encephalopathy. As an attempt to decompress the portal venous system, portal flow is derived into the systemic venous system through spontaneous portosystemic shunts (SPSSs), bypassing the liver. [...]
2020 - 10.1177/1756284820961287
Therapeutic Advances in Gastroenterology, Vol. 13 (september 2020)  
Registre complet - Creative Commons

Documents de recerca 1 registres trobats  
1.
61 p, 1.8 MB Estudio del papel fisiopatológico de la resistencia a la insulina en la cirrosis / Erice Muñoz, Eva ; Solà Lamoglia, Ricard, dir. ; Garcia-Pagan, Juan Carlos, dir. ; Bosch Genover, J., dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Los factores de riesgo cardiovascular, como la hipertensión arterial, la diabetes o la dislipemia, están íntimamente relacionados con el fenómeno de resistencia a la insulina, mecanismo fisiopatológico responsable de la aparición de disfunción endotelial y del desarrollo de complicaciones cardiovasculares. [...]
Cardiovascular factors, such as arterial hypertension, dyslipemia or diabetes are associated with insulin resistance, which is responsible for development of endothelial dysfunction and consequently cardiovascular diseases. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2015  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem